Morphic (MORF) News Today $24.95 +0.54 (+2.21%) (As of 12/4/2023 ET) Add Compare Share Share Today's Range$24.25▼$25.0450-Day Range$19.95▼$24.9552-Week Range$19.34▼$63.08Volume401,363 shsAverage Volume643,546 shsMarket Capitalization$1.24 billionP/E RatioN/ADividend YieldN/APrice Target$61.71 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRobbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investorstmcnet.com - December 1 at 6:56 PMWall Street Analysts See a 150.17% Upside in Morphic Holding, Inc. (MORF): Can the Stock Really Move This High?finance.yahoo.com - December 1 at 1:55 PMBrokerages Set Morphic Holding, Inc. (NASDAQ:MORF) PT at $61.71americanbankingnews.com - November 28 at 1:34 AMMORF SHAREHOLDERS: Investors of Morphic Holdings, Inc. Should Contact Robbins LLP for Information About Our Investigationbenzinga.com - November 27 at 8:26 PMMORF NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Morphic Holding Company Shareholdersbenzinga.com - November 22 at 6:35 PMMorphic Holding, Inc. Reminder: Robbins LLP is Investigating MORF on Behalf of Investorsbenzinga.com - November 22 at 6:35 PMWall Street Analysts Think Morphic Holding, Inc. (MORF) Could Surge 160.84%: Read This Before Placing a Betfinance.yahoo.com - November 15 at 3:51 PMMorphic to Present at November Investor Conferencesfinance.yahoo.com - November 10 at 9:01 AMMorphic Holding, Inc. (MORF) Moves to Buy: Rationale Behind the Upgradefinance.yahoo.com - November 9 at 2:37 PMPromising Clinical Progress and Future Trials Reinforce Buy Rating for Morphic Holding’s Stock (MORF)markets.businessinsider.com - November 7 at 1:29 AMSeigerman Recommends Buy for Morphic Holding Amid Solid Financial Position, Successful Clinical Trials, and Potential Future Catalystsmarkets.businessinsider.com - November 7 at 1:29 AMPromising Clinical Progress and Solid Financial Positioning Bolster Buy Rating for Morphic Holdingmarkets.businessinsider.com - November 6 at 10:17 AMMorphic Therapeutic: Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023finanznachrichten.de - November 3 at 1:11 PMMorphic Holding Inc (MORF) Reports Q3 2023 Loss of $36.2 Million, Ends Quarter with $725.finance.yahoo.com - November 3 at 1:11 PMMorphic Holding Inc (MORF) Reports Q3 2023 Loss of $36.2 Million, Ends Quarter with $725. ...finance.yahoo.com - November 3 at 1:11 PMMorphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023finance.yahoo.com - November 3 at 8:11 AMMorphic Under Investigation: Shareholders Are Encouraged to Contact Johnson Fistel for Their Optionsbenzinga.com - November 2 at 8:09 PMAnalysts Offer Insights on Technology Companies: Coursera (COUR), Intel (INTC) and Morphic Holding (MORF)markets.businessinsider.com - October 28 at 10:23 AMMorphic Holding Investigation: Johnson Fistel Encourages Shareholders with Losses to Contact the Firm Regarding Investigationstockhouse.com - October 19 at 5:23 PMStifel Nicolaus Sticks to Their Hold Rating for Morphic Holding (MORF)markets.businessinsider.com - October 16 at 1:15 AMMorphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigationbenzinga.com - October 13 at 11:50 PMThis Morphic Holding Insider Increased Their Holding By 16% Last Yearfinance.yahoo.com - October 13 at 1:48 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Morphic Holding, Inc. (MORF)benzinga.com - October 9 at 8:05 PMMorphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Setfinance.yahoo.com - October 9 at 8:30 AMWhere Morphic Holding Stands With Analystsmarkets.businessinsider.com - September 30 at 7:33 PMRhumbline Advisers Purchases 6,696 Shares of Morphic Holding, Inc. (NASDAQ:MORF)marketbeat.com - September 29 at 5:41 PMMorphic Holding: The Price Drop Is Very Interestingmsn.com - September 28 at 7:20 PMMorphic (NASDAQ:MORF) Resumes Slide After CEO Takes Temporary Leavemsn.com - September 27 at 1:52 PMMorphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absencefinance.yahoo.com - September 26 at 7:20 PMMorphic cut to Neutral at BTIG citing concerns over lead assetseekingalpha.com - September 26 at 9:18 AMStifel Maintains Morphic Holding (MORF) Hold Recommendationnasdaq.com - September 25 at 11:55 PMBTIG Downgrades Morphic Holding (MORF)msn.com - September 25 at 11:55 PMMorphic Therapeutic's Stock Plunges On Monday - Here's Why?markets.businessinsider.com - September 25 at 6:55 PMMorphic Therapeutic stock nosedives on disappointing trial databizjournals.com - September 25 at 1:54 PMThe Surprise That Prompted Morphic Therapeutic To Dump 52% Over Two Daysfinance.yahoo.com - September 25 at 1:54 PMMorphic (NASDAQ:MORF) Given New $33.00 Price Target at Stifel Nicolausmarketbeat.com - September 25 at 12:14 PMAnalysts Offer Insights on Technology Companies: Morphic Holding (MORF), Electronic Arts (EA) and Toast Inc (TOST)markets.businessinsider.com - September 25 at 8:54 AMMorphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023finance.yahoo.com - September 22 at 10:19 PMBoxer Capital LLC Buys Shares of 200,000 Morphic Holding, Inc. (NASDAQ:MORF)marketbeat.com - September 12 at 4:02 AMMorphic Holding Inc CFO and COO Marc Schegerin Sells 20,000 Sharesfinance.yahoo.com - September 9 at 5:21 PM5,843 Shares in Morphic Holding, Inc. (NASDAQ:MORF) Purchased by FORA Capital LLCmarketbeat.com - September 8 at 6:32 AMProsight Management LP Sells 34,485 Shares of Morphic Holding, Inc. (NASDAQ:MORF)marketbeat.com - September 7 at 2:55 PMMorphic Announces Participation in 2023 Wells Fargo Healthcare Conferencefinance.yahoo.com - August 29 at 12:46 PMIndustrial Alliance Investment Management Inc. Makes New $1.87 Million Investment in Morphic Holding, Inc. (NASDAQ:MORF)marketbeat.com - August 25 at 9:54 AMMorphic Holding, Inc. (NASDAQ:MORF) Stock Holdings Trimmed by Connor Clark & Lunn Investment Management Ltd.marketbeat.com - August 24 at 5:20 AMPictet Asset Management SA Invests $11.21 Million in Morphic Holding, Inc. (NASDAQ:MORF)marketbeat.com - August 22 at 5:53 AMMorphic Holding, Inc. (NASDAQ:MORF) Shares Sold by Barclays PLCmarketbeat.com - August 21 at 4:35 AMMorphic Holding, Inc. (NASDAQ:MORF) Receives Average Rating of "Moderate Buy" from Analystsmarketbeat.com - August 17 at 4:24 AMStifel cuts Morphic to hold, doesn't see it as near-term M&A targetseekingalpha.com - August 9 at 9:04 PMMorphic to Present at the Canaccord Genuity 43rd Annual Growth Conferencefinance.yahoo.com - August 9 at 9:04 PM Get Morphic News Delivered to You Automatically Sign up to receive the latest news and ratings for MORF and its competitors with MarketBeat's FREE daily newsletter. Email Address MORF Media Mentions By Week MORF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MORF News Sentiment▼0.430.70▲Average Medical News Sentiment MORF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MORF Articles This Week▼22▲MORF Articles Average Week Get Morphic News Delivered to You Automatically Sign up to receive the latest news and ratings for MORF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Viking Therapeutics News Today Xencor News Today OPKO Health News Today Kiniksa Pharmaceuticals News Today CureVac News Today Syndax Pharmaceuticals News Today Agios Pharmaceuticals News Today Aurinia Pharmaceuticals News Today Arcus Biosciences News Today Pacira BioSciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:MORF) was last updated on 12/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Morphic Holding, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.